|
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up |
|
|
|
Title: |
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up |
Author: |
Chalmers, Anna W. Patel, Shiven Boucher, Ken Cannon, Laura Esplin, Michelle Luckart, Julie Graves, Natalie Duren, Terry Van Akerley, Wallace |
Appeared in: |
Targeted oncology |
Paging: |
Volume 14 (2019) nr. 4 pages 417-421 |
Year: |
2019 |
Contents: |
|
Publisher: |
Springer International Publishing, Cham |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|